"bevacizumab" meaning in All languages combined

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "beva-",
        "3": "-ci-",
        "4": "-zumab",
        "qq1": "of unknown origin",
        "t2": "cardiovascular",
        "t3": "humanized monoclonal antibody"
      },
      "expansion": "beva- (of unknown origin) + -ci- (“cardiovascular”) + -zumab (“humanized monoclonal antibody”)",
      "name": "af"
    }
  ],
  "etymology_text": "From beva- (of unknown origin) + -ci- (“cardiovascular”) + -zumab (“humanized monoclonal antibody”).",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "bevacizumab (uncountable)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        {
          "kind": "other",
          "name": "English entries with incorrect language header",
          "parents": [
            "Entries with incorrect language header",
            "Entry maintenance"
          ],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English terms interfixed with -ci-",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English terms prefixed with beva-",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English terms suffixed with -zumab",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "topical",
          "langcode": "en",
          "name": "Pharmaceutical drugs",
          "orig": "en:Pharmaceutical drugs",
          "parents": [
            "Drugs",
            "Matter",
            "Pharmacology",
            "Chemistry",
            "Nature",
            "Biochemistry",
            "Medicine",
            "Sciences",
            "All topics",
            "Biology",
            "Fundamental"
          ],
          "source": "w"
        }
      ],
      "glosses": [
        "An anticancer drug that is a genetically engineered monoclonal antibody administered intravenously to slow or inhibit tumor growth especially in some metastatic forms of cancer (such as colorectal cancer). It acts by binding to and inhibiting the activity of vascular endothelial growth factor, a protein that promotes the growth of new blood vessels which supply a spreading tumor. It is marketed under the trademark Avastin."
      ],
      "id": "en-bevacizumab-en-noun-nry2cVxv",
      "links": [
        [
          "pharmacology",
          "pharmacology"
        ],
        [
          "anticancer",
          "anticancer"
        ],
        [
          "genetically engineered",
          "genetically engineered"
        ],
        [
          "monoclonal antibody",
          "monoclonal antibody"
        ],
        [
          "intravenously",
          "intravenously"
        ],
        [
          "metastatic",
          "metastatic"
        ],
        [
          "vascular endothelial growth factor",
          "vascular endothelial growth factor"
        ],
        [
          "blood vessel",
          "blood vessel"
        ]
      ],
      "raw_glosses": [
        "(pharmacology) An anticancer drug that is a genetically engineered monoclonal antibody administered intravenously to slow or inhibit tumor growth especially in some metastatic forms of cancer (such as colorectal cancer). It acts by binding to and inhibiting the activity of vascular endothelial growth factor, a protein that promotes the growth of new blood vessels which supply a spreading tumor. It is marketed under the trademark Avastin."
      ],
      "tags": [
        "uncountable"
      ],
      "topics": [
        "medicine",
        "pharmacology",
        "sciences"
      ],
      "wikipedia": [
        "bevacizumab"
      ]
    }
  ],
  "sounds": [
    {
      "ipa": "/ˌbɛv.əˈsɪz.ʊˌmæb/",
      "tags": [
        "General-American"
      ]
    }
  ],
  "word": "bevacizumab"
}

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "beva-",
        "3": "-ci-",
        "4": "-zumab",
        "qq1": "of unknown origin",
        "t2": "cardiovascular",
        "t3": "humanized monoclonal antibody"
      },
      "expansion": "beva- (of unknown origin) + -ci- (“cardiovascular”) + -zumab (“humanized monoclonal antibody”)",
      "name": "af"
    }
  ],
  "etymology_text": "From beva- (of unknown origin) + -ci- (“cardiovascular”) + -zumab (“humanized monoclonal antibody”).",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "bevacizumab (uncountable)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        "English 5-syllable words",
        "English entries with incorrect language header",
        "English lemmas",
        "English nouns",
        "English terms interfixed with -ci-",
        "English terms prefixed with beva-",
        "English terms suffixed with -zumab",
        "English terms with IPA pronunciation",
        "English uncountable nouns",
        "en:Pharmaceutical drugs"
      ],
      "glosses": [
        "An anticancer drug that is a genetically engineered monoclonal antibody administered intravenously to slow or inhibit tumor growth especially in some metastatic forms of cancer (such as colorectal cancer). It acts by binding to and inhibiting the activity of vascular endothelial growth factor, a protein that promotes the growth of new blood vessels which supply a spreading tumor. It is marketed under the trademark Avastin."
      ],
      "links": [
        [
          "pharmacology",
          "pharmacology"
        ],
        [
          "anticancer",
          "anticancer"
        ],
        [
          "genetically engineered",
          "genetically engineered"
        ],
        [
          "monoclonal antibody",
          "monoclonal antibody"
        ],
        [
          "intravenously",
          "intravenously"
        ],
        [
          "metastatic",
          "metastatic"
        ],
        [
          "vascular endothelial growth factor",
          "vascular endothelial growth factor"
        ],
        [
          "blood vessel",
          "blood vessel"
        ]
      ],
      "raw_glosses": [
        "(pharmacology) An anticancer drug that is a genetically engineered monoclonal antibody administered intravenously to slow or inhibit tumor growth especially in some metastatic forms of cancer (such as colorectal cancer). It acts by binding to and inhibiting the activity of vascular endothelial growth factor, a protein that promotes the growth of new blood vessels which supply a spreading tumor. It is marketed under the trademark Avastin."
      ],
      "tags": [
        "uncountable"
      ],
      "topics": [
        "medicine",
        "pharmacology",
        "sciences"
      ],
      "wikipedia": [
        "bevacizumab"
      ]
    }
  ],
  "sounds": [
    {
      "ipa": "/ˌbɛv.əˈsɪz.ʊˌmæb/",
      "tags": [
        "General-American"
      ]
    }
  ],
  "word": "bevacizumab"
}